Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Injections × Clear all

NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00034333 2005-06-24

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Phase 2/3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms